GSK PLC (GSK) RNS Announcements | Ticker

Date	Time	Date	TitleTitle (filtered)
27/04/26	12:00:02	27 Apr 2026	Efimosfermin granted US/EU regulatory designations	Efimosfermin granted US/EU regulatory designations
27/04/26	07:00:09	27 Apr 2026	TESARO update on AnaptysBio Inc. litigation	TESARO update on AnaptysBio Inc. litigation
24/04/26	15:30:00	24 Apr 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
23/04/26	07:00:04	23 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
22/04/26	07:00:02	22 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
21/04/26	07:00:03	21 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
20/04/26	15:30:01	20 Apr 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
20/04/26	07:00:05	20 Apr 2026	Blenrep approved in China for 2L+ multiple myeloma	Blenrep approved in China for 2L+ multiple myeloma
20/04/26	07:00:04	20 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
17/04/26	07:00:03	17 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
16/04/26	15:30:01	16 Apr 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
16/04/26	07:00:02	16 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
15/04/26	07:12:06	15 Apr 2026	GSK completes acquisition of 35Pharma Inc.	GSK completes acquisition of 35Pharma Inc.
15/04/26	07:00:04	15 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
14/04/26	15:30:00	14 Apr 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
14/04/26	07:00:02	14 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
13/04/26	15:30:00	13 Apr 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
13/04/26	07:00:05	13 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
13/04/26	07:00:04	13 Apr 2026	GSK presents positive data for BEHOLD 1 B7 H4 ADC	GSK presents positive data for BEHOLD 1 B7 H4 ADC
10/04/26	15:30:00	10 Apr 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
10/04/26	07:00:04	10 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
09/04/26	15:30:01	9 Apr 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
09/04/26	07:00:03	9 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
08/04/26	07:00:09	8 Apr 2026	Exdensur approved for CRSwNP in China	Exdensur approved for CRSwNP in China
08/04/26	07:00:04	8 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
07/04/26	07:00:05	7 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
02/04/26	07:00:02	2 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
01/04/26	15:30:01	1 Apr 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
01/04/26	15:00:00	1 Apr 2026	Total Voting Rights	Total Voting Rights
01/04/26	07:00:08	1 Apr 2026	ViiV completes changes to minority shareholding	ViiV completes changes to minority shareholding
01/04/26	07:00:05	1 Apr 2026	Transaction in Own Shares	Transaction in Own Shares
31/03/26	07:00:03	31 Mar 2026	Transaction in Own Shares	Transaction in Own Shares
30/03/26	07:05:00	30 Mar 2026	Bepirovirsen accepted for review in China	Bepirovirsen accepted for review in China
30/03/26	07:00:13	30 Mar 2026	Exdensur approved for severe asthma in China	Exdensur approved for severe asthma in China
30/03/26	07:00:07	30 Mar 2026	Transaction in Own Shares	Transaction in Own Shares
27/03/26	07:00:08	27 Mar 2026	Bepirovirsen accepted for review by the EMA	Bepirovirsen accepted for review by the EMA
27/03/26	07:00:03	27 Mar 2026	Transaction in Own Shares	Transaction in Own Shares
26/03/26	07:00:04	26 Mar 2026	Transaction in Own Shares	Transaction in Own Shares
25/03/26	15:30:00	25 Mar 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
25/03/26	13:00:00	25 Mar 2026	Notice of AGM	Notice of AGM
25/03/26	07:00:05	25 Mar 2026	Transaction in Own Shares	Transaction in Own Shares
24/03/26	07:00:07	24 Mar 2026	Transaction in Own Shares	Transaction in Own Shares
23/03/26	15:30:01	23 Mar 2026	Director/PDMR Shareholding	Director/PDMR Shareholding
23/03/26	15:00:00	23 Mar 2026	Admission to Trading	Admission to Trading
23/03/26	07:00:13	23 Mar 2026	GSK Lung Cancer ADC Gets Japan Orphan Drug Status	GSK Lung Cancer ADC Gets Japan Orphan Drug Status
23/03/26	07:00:06	23 Mar 2026	Transaction in Own Shares	Transaction in Own Shares
20/03/26	07:00:06	20 Mar 2026	Transaction in Own Shares	Transaction in Own Shares
19/03/26	12:00:00	19 Mar 2026	Lynavoy (linerixibat) approved by US FDA	Lynavoy (linerixibat) approved by US FDA
19/03/26	07:00:09	19 Mar 2026	Transaction in Own Shares	Transaction in Own Shares
18/03/26	15:30:01	18 Mar 2026	Director/PDMR Shareholding	Director/PDMR Shareholding

27/04/26

Efimosfermin granted US/EU regulatory designations

27/04/26

TESARO update on AnaptysBio Inc. litigation

24/04/26

Director/PDMR Shareholding

23/04/26

Transaction in Own Shares

22/04/26

Transaction in Own Shares

21/04/26

Transaction in Own Shares